Apeloa Pharmaceutical Co., Ltd. (000739)

Overview

Apeloa Pharmaceutical Co.,Ltd, founded in 1989 and headquartered in Dongyang, the People's Republic of China, is a prominent provider of raw materials and intermediates for the pharmaceutical industry. The company serves numerous pharmaceutical factories within China and extends its services internationally. Apeloa Pharmaceutical is recognized for its contribution to the pharmaceutical sector through its extensive offerings that cater to various therapeutic areas.

Products and Services

Preparation Products: Apeloa Pharmaceutical boasts a diverse portfolio of preparation products that target critical health areas. This range includes:

• Cardio-cerebrovascular: These products are designed to support the health of the heart and the brain, addressing conditions such as hypertension, heart failure, and stroke prevention.
• Anti-infection: Offering solutions to combat bacterial, viral, and fungal infections, these drugs are vital in managing and treating infectious diseases across a broad spectrum.
• Anti-tumor: Catering to the oncology segment, these products play a significant role in the fight against various types of cancer, providing patients with chemotherapy options and supportive care treatments.
• Anti-viral: In response to the global need for effective antiviral therapies, Apeloa's products in this category offer treatments for diseases like influenza, hepatitis, and other viral infections.
• Special Drugs: This category encompasses a range of treatments for less common conditions and diseases, reflecting Apeloa's commitment to addressing the healthcare needs of niche patient populations.

The company markets its products under several brands, including Tianliwei, Beshin, Yosemade, Jutai, and others, ensuring its presence in different therapeutic segments and leveraging brand recognition to foster trust and reliability among healthcare professionals and patients.